Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Moleculin Biotech (MBRX) Shares Outstanding (2016 - 2025)

Moleculin Biotech's Shares Outstanding history spans 10 years, with the latest figure at $3.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $3.2 million for Q4 2025, up 2267.08% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 2267.08% YoY), and the annual figure for FY2025 was $3.2 million, up 2267.08%.
  • Shares Outstanding for Q4 2025 was $3.2 million at Moleculin Biotech, down from $49.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.5 million in Q3 2025 to a low of $89101.0 in Q4 2023.
  • The 5-year median for Shares Outstanding is $3.1 million (2024), against an average of $14.3 million.
  • The sharpest move saw Shares Outstanding plummeted 99.98% in 2021, then surged 1144168.24% in 2022.
  • Year by year, Shares Outstanding stood at $1.9 million in 2021, then increased by 0.17% to $1.9 million in 2022, then plummeted by 95.33% to $89101.0 in 2023, then skyrocketed by 51.69% to $135155.0 in 2024, then soared by 2267.08% to $3.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $3.2 million, $49.5 million, and $30.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.